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Abstract 
Objective We examined the association between different adiposity indices and pulmonary 
function in Chinese adults in the Guangzhou Biobank Cohort Study (GBCS).  
Methods Participants with body mass index (BMI) <18.5 (underweight) were excluded. 
Adiposity indices including BMI, waist circumference (WC), waist hip ratio, waist height 
ratio and body fat percentage were measured. Lung function was assessed by spirometry 
using a turbine flowmeter. We analyzed percent predicted for forced expiratory volume in 1 
second (FEV1%), forced vital capacity (FVC %) and restrictive respiratory defect (FEV1 
/FVC ratio >low limits of normal and FVC % <0.80).  
Results Of 16186 participants (mean age 61.4±7.2 years; 74.0% women), 116 (0.7%) had 
general obesity only (BMI ≥28 kg/m2), 4079 (25.2%) had central obesity only (WC: ≥90 
cm in men, ≥80 cm in women) and 1591 (9.8%) had both central obesity and general 
obesity. Comparing to those with neither central nor general obesity, those with central 
adiposity only and with both central and general obesity had lower pulmonary function 
(adjusted β range from -2.85 to -6.02 for FEV1% and FVC%, adjusted OR range from 1.14 to 
1.70, all P <0.05). But those with general obesity only had better but non-significant 
pulmonary function. (Crude β range from 1.46 to 2.92 for FEV1% and FVC%, crude OR 
range from 0.68 to 0.93, all P >0.05). Both FEV1% and FVC% decreased per standard 
deviation increase in obesity indices (adjusted β from -0.46 to -3.17, all P <0.002). A positive 
association of central or general obesity with restrictive respiratory defect was observed 
(adjusted odds ratio (AOR) from 1.50 to 2.04, all P <0.002). Further adjustment for WC 
reversed the inverse association between BMI and pulmonary function (adjusted β from 1.93 
to 6.22, all P <0.001) and restrictive respiratory defect (adjusted AOR from 0.72 to 0.80, all P 
<0.001).  
Conclusion: Central adiposity and its indices, but not general adiposity and BMI, were 
independently associated with lower pulmonary function and higher risk of restrictive 
respiratory defect in older Chinese. (331 words) 
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Introduction  
The prevalence of obesity has been rising rapidly over the past decade to become a 
worldwide disease burden [1]. Obesity is well recognized as a risk factors for type 2 diabetes, 
cardiovascular diseases [2] and cancers [3]. Poor pulmonary function (low forced expiratory 
volume in 1 second (FEV1) ) is an important long-term predictor of mortality in the general 
population [4] and in particular a marker for cardiovascular mortality[5]. While body mass 
index (BMI) is the most widely used general adiposity measure[6], indices of central 
adiposity may be better predictors for future cardiovascular risk [7, 8].  
 
Many studies have explored the relationship between adiposity indices and lung function, 
with most [9-14], but not all [15] of these studies showing an inverse association of 
pulmonary function with central obesity and its indices. While some studies showing an 
inverse association[9, 11, 12] and others showing a weak or non-significant association 
[15-17] of pulmonary function with BMI and general obesity. Interaction by sex and smoking 
were seldom tested in previous studies[9]. The few studies that have examined the influences 
of different obesity indices on lung function were mainly based on Western populations[11, 
12], while Asians have a more central distribution of adipose tissue than Caucasians at the 
same BMI[18].We found only one study on 770 participants reporting forced vital capacity 
(FVC) %, but not FEV1, was lower in overweight subjects instead of general obesity subjects 
in Xi'an[19]. Few papers explored which adiposity indices were independently associated 
with pulmonary function, only two papers adjusted BMI in analyzing the associations 
between central obesity indices and pulmonary function[11, 14], one of them indicating that 
adjustments strengthened the inverse association[14]. 
 
Hence, we analyzed the baseline data from the Guangzhou Biobank Cohort Study (GBCS) to 
further explore the association of different adiposity indices and pulmonary function. 
 
Methods 
Study participants  
Guangzhou Biobank Cohort Study (GBCS) is a three-way collaboration among the 
Guangzhou Number 12 Hospital, the Universities of Hong Kong and Birmingham. A total of 
30430 older Chinese (aged 50 years or over) in Guangzhou were recruited at baseline from 
2003 to 2008, and details have been reported [20]. The Guangzhou Medical Ethics 
Committee of the Chinese Medical Association approved the study and all participants gave 
written informed consent before participation. 
 
Briefly, trained interviewers used a standardized computer-based questionnaire to collect 
information on the demographic characteristics, family and personal disease history and 
lifestyle, including smoking and alcohol drinking. The Chinese version of the International 
Physical Activity Questionnaire (IPAQ-C) which was validated by us was used for assessing 
physical activity [21]. IPAQ data were converted to metabolic equivalent scores for each type 
of activity, and were categorized to 3 groups of low, moderate and high levels of activity.  
 
Body weight and height were measured using standardized protocols and instruments, height 
in bare feet was measured to the nearest 0.5 cm using a Holtain stadiometer and weight in 
light clothes using standardized scales to the nearest 0.5 kilogram using a weighing apparatus 
(RGZ-120-RT, Wuxi weighing apparatus factory, Wuxi, China). by trained researchers [20]. 
BMI was calculated as weight divided by square of the height (kg/m2). General obesity was 
defined using a BMI cut-off point ≥28 kg/m2, based on the criteria of the National Health 
and Family Planning Commission of the People's Republic of China [22], with BMI 
18.5-23.9 kg/m2 classified as healthy weight and 24-27.9 kg/m2 as Overweight. We did not 
include participants whose BMI <18.5 (underweight) in our study because the mechanism for 
pulmonary function in those participants would be different from that in other BMI groups.  
 
Waist circumferences (WC) was taken as the minimum circumference between the umbilicus 
and xiphoid process, and central obesity was defined by WC ≥90 cm in men and ≥80 cm 
in women [23]. Hip circumference was measured as the maximum circumference around the 
buttocks and the symphysis pubis. Waist hip ratio (WHR) was calculated as WC divided by 
hip circumference. Waist height ratio (WHtR) was calculated as WC divided by height. Body 
fat percentage was measured using a bioelectrical impedance analyzer analyzer (Tanita 
BF350, Tanita Inc., Japan). These data had been used in several GBCS papers[24, 25]. 
 
For comparison, obesity indices were standardized using Z score transformation to analyze 
the association with pulmonary function. The standard deviation (SD) of BMI, WC, WHR, 
WHtR and body fat percentage was 3.3kg/m2, 9.0 cm, 7%, 6% and 8% in whole study, 
respectively. Sex specific SDs were used in different sex group. 
 
Spirometry was done with a pneumotachograph (Chestgraph HI-701, Chest MI Inc, Tokyo, 
Japan) in phase I and a turbine flowmeter (Cosmed microQuark, Rome, Italy) in phase II and 
two ultrasonic flowmeters (ndd Medical Technologies Easy-on PC; Zurich, Switzerland) in 
phase Ⅲ. Details of the methods have been reported elsewhere [26, 27]. Briefly, the 
pulmonary function test was conducted in a standing position following standard procedures, 
and at least three maneuvers and the best measure of FEV1 and FVC were recorded. Predicted 
values for FEV1 and FVC were derived using the equations developed by Ip and colleagues 
for Chinese [28]. The outcome variables were (1) FEV1 % predicted (FEV1 %),(2) FVC % 
predicted (FVC %) and (3) restrictive respiratory defect (FEV1 /FVC ratio ≥lower limits of 
normal (LLN) and FVC% <0.80)[29]. 
 
Statistical analysis 
Continuous variables were analyzed using independent sample t-test and categorical variables 
using χ2 test. Regression model was used to assess the association between FEV1%, FVC% 
and presence of restrictive respiratory defect in different BMI groups and obesity type 
(normal, with general obesity only, with central obesity only and with both general and 
central obesity). The linearity of the association between adiposity measures and pulmonary 
function was examined using margins, with marginal linear prediction plotted on the y-axis 
and WC/BMI as a continuous variable on the x-axis. The results showed no evidence for the 
non-linearity for both BMI and WC (Figures not shown), supporting the use of multiple 
linear regression to calculate regression coefficient (β) and 95% confidence interval (CI) for 
the association between different obesity status and adiposity indices (continuous variables) 
and pulmonary function measurements with adjustment for age, height, education (≤primary, 
middle school and ≥college), smoking (never, former and current smokers), occupation 
(manual, non-manual and others), physical activity (low, moderate and high level), airflow 
obstruction, self-reported asthma and wheezing as appropriate. Multivariable logistic 
regression was used to calculate the odds ratio (OR) of the presence of restrictive respiratory 
defect according to central and general obesity (as dichotomous variables) and obesity indices 
with adjustment for the same confounders above. WC was further adjusted in the regression 
model of general obesity and BMI and pulmonary function, while BMI further adjusted in the 
model of central obesity and WC and pulmonary function. To detect the existence of 
potential multicollinearity, we calculated variance inflation factors (VIF) for linear regression 
models to quantify how much the variance was inflated. A VIF value of less than 2 usually 
means multicollinearity is ignorable[30]. For all models including both BMI and WC, all 
VIFs were less than 2.0, indicating the problem of multicollinearity might not be a major 
concern. Moreover, the mutual adjustment of BMI and WC was done to assess the 
independent association of these adiposity measures with pulmonary function, and this 
method has been used by many other studies to assess their independent associations with 
other health conditions or mortality[31-34]. 
 
We tested for interaction between obesity and sex using likelihood ratio test for the fitness of 
models with or without the interaction terms. Models with a lower Akaike information 
criterion (AIC) value indicate better fitness. As there was evidence for sex interaction for the 
association between adiposity measures and pulmonary function, and body composition as 
well as lung volumes vary largely between men and women, all analyses were performed 
stratified by sex. All tests of significance were 2-tailed, with P <0.05 as statistically 
significant. All analyses were performed using Stata / SE 12.0 (StataCorp LP, 4905 Lakeway 
Drive, College Station, TX77845 USA). 
 
Results  
Of 30430 participants in GBCS study, after excluding those with BMI <18.5 (underweight), 
16186 (53.2%) with valid data were included in this analysis [7]. The mean (± standard 
deviation) age was 61.4±7.2 years and most of them were women (74.0%). 116 (0.7%) 
participants were defined as having general obesity only, 4079 (25.2%) central obesity only, 
and 1591 (9.8%) having both central and general obesity. Table 1 shows that compared with 
those without, a higher proportion of those with central obesity were women and older, had 
lower socioeconomic position (lower education and more manual occupation), lower lung 
function, higher prevalence of restrictive respiratory defect and self reported wheezing, and 
were non-smokers.  
 
Table 2 shows that those with overweight and general obesity, as assessed by BMI, had lower 
FVC% than those with normal weight (β from -1.45 to -4.85, all P <0.01). FEV1% was lower 
in women who were obese (β -3.70, 95% CI -4.73 to -2.66), but not in those who were 
overweight (all p >0.05). The prevalence of restrictive respiratory defect was higher in those 
with overweight and general obesity (OR from -1.19 to -1.74, all P <0.01). Further adjusted 
for age, height, education, smoking, occupation, physical activity, airflow obstruction, 
self-reported asthma and wheezing did not change the results substantially, only the FEV1% 
became significantly lower in men with overweight and obesity (adjusted β -1.66 and -3.11, 
all P <0.01). 
 
Table 3 shows that those who had central obesity only and who had both central and general 
obesity had lower FEV1% and FVC% (β from -2.54 to -7.36, all P <0.01) and higher 
prevalence of restrictive respiratory defect (OR from -1.76 to -2.23, all P <0.01) than those 
with normal weight. Differences between those who had general obesity only and those 
without neither central nor general obesity were non-significant (all P >0.05). Further 
adjustment for the same confounders did not change the results substantially. 
 
Table 4 shows that after adjusting for confounders above, central obesity and its indices Z 
score (WC, WHtR, WHR and body fat) were significantly inversely associated with FVC% 
and FEV1%  (adjusted β from -1.27 to -5.39, all P <0.001), and higher risk of restrictive 
respiratory defect (AOR from1.17 to 2.04, all P <0.001). The inverse associations between 
general obesity and BMI Z score and FVC% and FEV1% were weaker than that of central 
obesity indices (adjusted β from -0.46 and -3.46, all P <0.001). Further adjustment of BMI 
strengthened the association between WC and FEV1% and FVC% (adjusted β -4.09 and -7.77, 
all P <0.001). After further adjustment of WC, BMI Z score became positively associated 
with FEV1% and FVC% (adjusted β from 1.93 to 6.22, P <0.001) and restrictive respiratory 
defect (AOR from 0.72 to 0.80, all P <0.001).  
 Table 4 also shows that the negative associations of obesity with lower FEV1, FVC and 
higher risk of restrictive respiratory defect were stronger in men than in women. After 
adjusting for WC, the positive association between BMI and pulmonary function was  
stronger in men than in women (most P values for sex interaction <0.05). But the associations 
of general obesity, WC, weight hip ratio, weight height ratio and body fat percentage with 
poorer pulmonary function did not vary by sex (P for sex interaction >0.05). As very few 
women (<2%) smoked in China, the interaction test between smoking and adiposity was 
conducted in men only (data not shown). We found no evidence that the association of 
pulmonary function with obesity varied by smoking status (most P for smoking interaction 
ranged from 0.11 to 0.80).  
 
Discussion 
Our study of older Chinese in Southern China showed that those with central obesity and 
those with both central and general obesity, but not those with general obesity only, had lower 
pulmonary function. We also found all obesity status and indices were associated with lower 
FEV1 and FVC (except BMI was not significantly associated with FEV1 in men) and higher 
presence of restrictive respiratory defect. Further adjustment of WC reversed the relationship 
between BMI with lung function substantially. Our results suggest that central obesity and its 
indices, rather than general obesity and BMI, are associated with poor lung function. The 
relationships stated above were similar in both gender and irrespective of smoking status.  
  
Previous studies showed that both central and general obesity were negatively associated with 
pulmonary function, but WC had better explanatory power than BMI [9]. Evidence on the 
association between BMI and FEV1 and FVC was complex and the results were inconclusive 
[9, 16, 35, 36], with one study reporting an inverted U-shaped relationship [35], some 
reporting a negative [9] or no [16, 36] and even positive [16, 36] associations, but none of 
them had further adjusted WC to clarify. On the other hand, some studies adjusted for BMI in 
exploring the relationships between central obesity indices and pulmonary function [11, 14], 
with one study showing that this strengthened the association between WC and pulmonary 
function [14]. One possible explanation for the positive association between BMI and 
pulmonary function could be due to reverse causation: people with chronic lung disease or 
poor lung function tended to lose muscle mass, and that leads to lower BMI. But lack of 
exercise due to the poor lung function can lead to high waist circumference. The mechanism 
by which central obesity may influence pulmonary function is different from that of general 
obesity. Central obesity may restrict the diaphragm movement and limit lung expansion while 
general obesity may compress the chest wall [37]. A reduction in the functional residual 
capacity due to mass load of adipose tissue around the rib cage and abdomen and in the 
visceral cavity might be one of the main mechanisms[38]. A systematic review showed that 
WC tends to be inversely associated with FEV1 and FVC [10].Although accepted worldwide 
as an important index for defining obesity, BMI cannot distinguish between the fat mass and 
fat free mass, and compartments of body composition including fat, bone, water and muscle. 
Several studies suggested that the fat distribution and fat mass amount have distinct effects on 
pulmonary function [39, 40]. The association of obesity with pulmonary function might be 
affected by the distribution of body fat [10], and central obesity was associated with 
respiratory mechanics regardless of BMI [11, 41].  
 
Our findings are broadly consistent with previous studies in the general population that 
reported a negative association between central and general adiposity and pulmonary function. 
The European Prospective Investigation into Cancer and Nutrition-Norfolk (EPIC-Norfolk) 
study found an inverse linear association of WHR with pulmonary function, and showed that 
the association remained significant in subjects without smoking and/or obesity [14]. The 
EPIC-Norfolk study suggested that WHR might be a better indicator than BMI in assessing 
the role of adiposity in predicting lung function in the general population. Few studies 
adjusted WC for general obesity or BMI for central obesity. However, in our study with a 
larger number of participants, all central obesity indices showed significantly association with 
poorer pulmonary function (lower FEV1 and FVC and higher risk of restrictive respiratory 
defect), which remained with further adjustment of BMI.  
 
Consistent with previous studies [9], We also found that the associations of adiposity indices 
with pulmonary function were stronger in men than in women (P for sex interaction from 
<0.001 to 0.35 for FVC), which may reflect gender differences in body fat distribution. Men 
have greater lean mass but less fat mass than women, but their fat mass tends to accumulate 
around the abdomen, while females deposit fat predominantly around the hips [42]. It is 
likely that visceral fat volume, rather than fat proportions, affects the reduction of 
diaphragmatic movement and chest-wall expansion [38]. As smoking is a major risk factors 
for poor pulmonary function, but smokers tend to have a lower BMI and higher WHR [43], 
the role of smoking in this association should be examined with caution. Our findings showed 
that the association of adiposity with pulmonary function was independent of smoking.  
 
There were several strengths in our study. First, we excluded participants with under-weight 
as they could have underlying diseases and the mechanisms and relationships for lung 
function could be different and complex. Pooling them together with normal weight people as 
a reference group could lead to unclear results, but only a few studies did exclude them [9, 17, 
36, 44]. Second, as adiposity indices were measured more comprehensively, we could explore 
the association of different adiposity indices with pulmonary function. Third, BMI and WC 
were mutually adjusted, which were seldom conducted in previous studies, to clarify the 
independent effects of different adiposity indices on lung function. Fourth, the large sample 
size and detailed assessment of potential confounders as well as effect modifiers also 
facilitate our demonstration of the independent effect of central obesity on pulmonary 
function.  
 
However, there were also some limitations. First, a causal inference could not be confirmed 
in the current cross-sectional study. Second, our sample size might not be enough to detect 
small but important interaction effects and much larger studies are needed. Third, we cannot 
completely rule out the possibility of reverse causality, which means that the higher levels of 
adiposity could be the result of reduction in physical activity due to poor pulmonary function. 
However, we adjusted for physical activity and the results of a sensitivity analysis examining 
the association in those with good and bad self-reported health were similar. Fourth, the 
sample size of participants with only general obesity was much less than that of participants 
with only central obesity and with both general and central obesity, that might lead to 
insufficient power to detect the significance of the difference.  
 
In conclusion, we found that central adiposity and its indices, but not general adiposity and 
BMI, were independently associated with lower pulmonary function and higher risk of 
restrictive respiratory defect in older Chinese. BMI was even positively associated with 
pulmonary function after controlling of WC. The association did not vary by sex or smoking 
status, though the negative associations of central obesity with lower pulmonary function 
were stronger in men. Previous observations on BMI might be inadequate and the 
relationships between BMI and pulmonary function might be confounded or mediated partly 
by WC, or confused by including pooling under-weight and normal weight subjects as a 
reference. Hence future studies should examine central obesity and accounting for general 
obesity. To maintain better pulmonary function in older Chinese with higher prevalence of 
central obesity, we might pay more attentions to controlling WC and central adiposity instead 
of BMI and general adiposity.  
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 Table 1. Demographic characteristics and clinical parameters by central obesity status 
(N=16186) 
 WC, waist circumference; IPAQ, International Physical Activity Questionnaire; FEV1, 
 Men    Women    
 Normal WC Central 
obesity 
P-value
s 
Normal WC Central 
obesity 
P-value
s 
Number  3366 837  7150 4833  
Men, n (%)        
Age, y, mean±SD 63.8±6.8 64.7±7.0 <0.001 59.4±7.0 62.1±7.1 <0.001 
Education, n (%)   0.54   <0.001 
  ≤Primary  959 (28.5) 242 (28.9)  2703 (37.8) 2736 (56.6)  
  Middle school 1851 (55.0) 445 (53.2)  3969 (55.5) 1862 (38.5)  
  ≥College 556 (16.5) 150 (17.9)  478 (6.7) 235 (4.9)  
Smoking, n (%)   <0.001   <0.001 
  Never 1289 (38.3) 324 (38.7)  6961 (97.4) 4640 (96.0)  
  Former 943 (28.0) 289 (34.5)  84 (1.2) 101 (2.1)  
  Current 1134 (33.7) 224 (26.8)  105 (1.5)  92 (1.9)  
IPAQ Physical 
activity, n (%) 
  0.92   0.01 
Low 281 (8.4) 71 (8.5)  633 (8.9) 381 (7.9)  
Moderate 1426 (42.4) 360 (43.0)  2568 (35.9) 1851 (38.3)  
High 1659 (49.3) 406 (48.5)  3949 (55.2) 2601 (53.8)  
Occupation, n (%)    0.91   <0.001 
Manual  1246 (37.0) 313 (37.4)  3010 (42.1) 2496 (51.6)  
Non-manual 1458 (43.3) 365 (43.6)  2450 (34.3) 1464 (37.4)  
Others  662 (19.7) 159 (19.0)  1690 (23.6) 873 (18.1)  
Airway Obstruction, n 
(%) 
200 (5.9) 34 (4.1) 0.03 363 (5.1) 258 (5.3) 0.53 
Self-reported 
wheezing, n (%) 
140 (4.2) 46 (5.5) 0.10 123 (1.7) 183 (3.8) <0.001 
Self-reported asthma, 
n (%) 
52 (1.9) 16 (2.3) 0.48 82 (1.3) 83 (2.0) 0.01 
Height, cm, mean±SD  164.0±5.8 166.3±6.2 <0.001 153.5±5.3 154.1±5.5 <0.001 
Body mass index, 
kg/m2, mean±SD 
23.0±2.3 27.5±2.4 <0.001 22.6±2.2 26.5±2.8 <0.001 
WC, cm, mean±SD 79.6±6.2 94.6±4.7 <0.001 72.6±4.6 86.2±5.5 <0.001 
Waist/hip ratio, 
mean±SD 
0.89±0.05 0.97±0.04 <0.001 0.82±0.05 0.90±0.06 <0.001 
Waist/height ratio, 
mean±SD 
0.49±0.04 0.57±0.03 <0.001 0.47±0.03 0.56±0.04 <0.001 
Body fat†, %, 
mean±SD 
22.3±5.0 29.1±4.7 <0.001 31.0±5.5 38.7±6.4 <0.001 
Restrictive respiratory 
defect, n (%) 
654 (20.7) 280 (34.9) <0.001 1026 (15.1) 1151 (25.2) <0.001 
FEV1, L, mean±SD 2.32±0.58 2.24±0.57 0.001 1.84±0.40 1.72±0.41 <0.001 
FEV1 %, %, 
mean±SD 
92.1±18.9 86.8±21.0 <0.001 96.9±17.2 92.3±18.0 <0.001 
FVC, L, mean±SD 3.00±0.66 2.88±0.64 <0.001 2.29±0.48 2.14±0.48 <0.001 
FVC %, %, mean±SD 91.8±16.7 85.4±19.2 <0.001 95.0±16.3 89.3±16.2 <0.001 
FEV1/FVC, %, 
mean±SD 
77.1±8.8 77.5±8.3 0.21 80.1±6.5 80.3±7.2 0.19 
forced expiratory volume in 1 second; FEV1 %, forced expiratory volume in 1 second % 
predicted; FVC, forced vital capacity; FVC %, forced vital capacity % predicted; 
Central obesity: waist circumference ≥90 cm in men or ≥80 cm in women.  
Airway obstruction: FEV1 /FVC ratio <lower limits of normal (LLN) without self-reported 
asthma. 
Restrictive respiratory defect: FEV1 /FVC ratio ≥LLN and FVC % <0.80. 
†: n=6397, missing values were excluded here only.  
 
Table 2. Association (regression coefficient β/ odd ratio, 95% confidence interval (CI)) of different BMI groups with Pulmonary function (N=16186) 
BMI: body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; CI: confidence interval; OR: odd ratio; 
Restrictive respiratory defect: FEV1 /FVC ratio ≥lower limits of normal and FVC % <0.80 
Normal: 18.5 ≤BMI < 24 kg/m2; Overweight: 24 ≤BMI < 28 kg/m2; Obesity: BMI ≥28 kg/m2; 
Adjustment include age, height, education, smoking, occupation, physical activity, airflow obstruction, self-reported asthma and wheezing as 
appropriate 
 N FEV1%, % FVC %, % Restrictive respiratory defect$ 
  Crude β (95% CI) Adjusted β (95% CI) Crude β (95% CI) Adjusted β (95% CI) Crude OR (95% CI) Adjusted OR (95  
CI) Men         
Normal  2280 0.00 0.00 0.00 0.00 1.00 1.00 
Overweight  1571 0.11 (-1.14 to 1.36) -1.66 (-2.89 to -0.44) -1.90 (-3.01 to -0.78) -2.74 (-3.92 to -1.56) 1.42 (1.21 to 1.66) 1.58 (1.32 to 1.90) 
Obesity  352 -1.01 (-3.20 to 1.17) -3.11 (-5.19 to -1.04) -3.32 (-5.27 to -1.37) -4.13 (-6.14 to -2.12) 1.68 (1.30 to 2.17) 1.89 (1.42 to 2.53) 
P-value  0.70 <0.001 <0.001 <0.001 <0.001 <0.001 
        
Women          
Normal  6202 0.00 0.00 0.00 0.00 1.00 1.00 
Overweight  4426 -0.38 (-1.06 to 0.30) -0.45 (-1.13 to 0.22) -1.45 (-2.08 to -0.81) -1.20 (-1.85 to -0.55) 1.19 (1.07 to 1.31) 1.16 (1.04 to 1.30) 
Obesity  1355 -3.70 (-4.73 to -2.66) -3.10 (-4.13 to -2.07) -4.85 (-5.81 to -3.88) -3.97 (-4.96 to -2.98) 1.74 (1.51 to 2.01) 1.60 (1.37 to 1.87) 
P-value   <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
 
Table 3. Association of different obesity status with Pulmonary function (N=16186) 
FEV1 %, forced expiratory volume in 1 second % predicted; FVC %, forced vital capacity % predicted; CI: confidence interval; OR: odd ratio; 
Restrictive respiratory defect: FEV1 /FVC ratio ≥lower limits of normal and FVC observed to predicted ratio <0.80. 
General obesity: BMI ≥28 kg/m2     
Central obesity: waist circumference ≥90 cm in men or ≥80 cm in women  
Adjustment include age, height, education, smoking, occupation, physical activity, airflow obstruction, self-reported asthma and wheezing as 
appropriate 
 N FEV1%, % FVC %, % Restrictive respiratory defect 
  Crude β (95% CI) Adjusted β (95% CI) Crude β (95% CI) Adjusted β (95% CI) Crude OR (95% CI) 
Adjusted OR (9  
CI) 
Men         
Normal  3319 0.00 0.00 0.00 0.00 1.00 1.00 
General obesity only 47 1.46 (-4.10 to 7.02) -2.24 (-7.73 to 3.25) 1.98 (-2.97 to 6.94) -0.69 (-6.00 to 4.63) 0.93 (0.45 to 1.94) 1.12 (0.48 to 2.62  
Central obesity only 532 -6.87 (-8.63 to -5.10) -5.86 (-7.64 to -4.08) -7.36 (-8.93 to -5.78) -6.20 (-7.92 to -4.48) 2.23 (1.82 to 2.72) 1.70 (1.29 to 2.24  
General and central 
obesity 
305 -2.54 (-4.81 to -0.28) -3.31 (-5.44 to -1.17) -4.42 (-6.44 to -2.40) -4.20 (-6.27 to -2.14) 1.76 (1.37 to 2.30) 1.42 (1.03 to 1.95  
P-value  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
        
Women          
Normal  7081 0.00 0.00 0.00 0.00 1.00 1.00 
General obesity only 69 2.82 (-1.32 to 6.97) 2.45 (-1.61 to 6.51) 2.92 (-0.930 to 6.77) 1.89 (-2.00 to 5.78) 0.68 (0.31 to 1.48) 1.03 (0.46 to 2.31  
Central obesity only 3547 -4.27 (-4.98 to -3.57) -2.85 (-3.58 to -2.13) -5.59 (-6.25 to -4.94) -3.53 (-4.23 to -2.83) 1.80 (1.63 to 2.00) 1.14 (0.99 to 1.31  
General and central 
obesity 
1286 -5.38 (-6.42 to -4.34) -4.27 (-5.32 to -3.23) -6.60 (-7.56 to -5.63) -5.07 (-6.07 to -4.07) 2.11 (1.83 to 2.43) 1.41 (1.18 to 1.68  
P-value  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Table 4. Association (adjusted regression coefficient β/odd ratio, 95% confidence interval 
(CI)) of obesity indices with pulmonary function in all participants see above and by sex 
 Men  Women 
 
 
 β (95% CI) P β (95% CI) P 
FEV1%, %     
Central obesity -4.82 (-6.26 to -3.37) <0.001 -3.26 (-3.92 to -2.60) <0.001 
General obesity -2.40 (-4.40 to -0.39) 0.02 -2.91 (-3.90 to -1.92) <0.001 
WC, SD   -2.60 (-3.23 to -1.97) <0.001 -2.22 (-2.58 to -1.86) <0.001 
WC, SD*  -7.66 (-8.81 to -6.51) <0.001 -4.09 (-4.67 to -3.52) <0.001 
BMI, SD  -0.46 (-1.11 to 0.20) 0.17 -0.78 (-1.11 to -0.44) <0.001 
BMI, SD＃  6.22 (-5.03 to 7.41) <0.001 2.24 (1.70 to 2.77) <0.001 
WHR, SD  -2.86 (-3.52 to -2.20) <0.001 -2.16 (-2.51 to -1.82) <0.001 
WHtR, SD  -2.51 (-3.16 to -1.86) <0.001 -2.15 (-2.50 to -1.81) <0.001 
Body fat %, SD† -1.48 (-2.88 to -0.09) 0.04 -1.27 (-1.81 to -0.73) <0.001 
     
FVC%, %     
Central obesity -5.39 (-6.79 to -4.00) <0.001 -3.97 (-4.60 to -3.33) <0.001 
General obesity -2.95 (-4.90 to -1.01) 0.003 -3.46 (-4.40 to -2.51) <0.001 
WC, SD -3.17 (-3.78 to -2.57) <0.001 -2.67 (-3.01 to -2.33) <0.001 
WC, SD* -7.77 (-8.87 to -6.66) <0.001 -4.29 (-4.84 to -3.74) <0.001 
BMI, SD -1.12 (-1.76 to -0.48) 0.001 -1.22 (-1.55 to -0.90) <0.001 
BMI, SD＃ 5.65 (4.50 to 6.80) <0.001 1.93 (1.42 to 2.45) <0.001 
WHR, SD  -3.15 (-3.78 to -2.51) <0.001 -2.45 (-2.78 to -2.11) <0.001 
WHtR, SD  -3.09 (-3.72 to -2.46) <0.001 -2.60 (-2.93 to -2.26) <0.001 
Body fat %, SD† -2.29 (-3.64 to -0.95) 0.001 -1.82 (-2.32 to -1.32) <0.001 
     
Presence of 
restrictive 
respiratory defect 
Odds ratio (95% CI) P Odds ratio (95% CI) P 
Central obesity 2.04 (1.67 to 2.49) <0.001 1.53 (1.38 to 1.71) <0.001 
General obesity 1.53 (1.16 to 2.02) 0.002 1.50 (1.29 to 1.74) <0.001 
WC, SD   1.53 (1.39 to 1.68) <0.001 1.35 (1.27 to 1.43) <0.001 
WC, SD*  2.02 (1.67 to 2.43) <0.001 1.62 (1.48 to1.78) <0.001 
BMI, SD  1.31 (1.19 to 1.44) <0.001 1.15 (1.09 to 1.21) <0.001 
BMI, SD＃ 0.72 (0.59 to 0.87) 0.001 0.80 (0.73 to 0.88) <0.001 
WHR, SD  1.43 (1.29 to 1.58) <0.001 1.31 (1.24 to 1.39) <0.001 
WHtR, SD  1.54 (1.39 to 1.70) <0.001 1.34 (1.26 to 1.42) <0.001 
Body fat %, SD† 1.55 (1.23 to 1.95) <0.001 1.17 (1.05 to 1.31) 0.006 
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; WC, waist 
circumference; BMI, body mass index; WHR, waist hip ratio; WHtR, waist height ratio;  
General obesity: BMI ≥28 kg/m2  
Central obesity: waist circumference ≥90 cm in men or ≥80 cm in women  
Restrictive respiratory defect: FEV1/FVC ratio ≥lower limits of normal and FVC % <0.80 
1SD BMI =2.92 kg/m2 in men, =3.12 kg/m2 in women 
1SD WC=8.43 cm in men, =8.30 cm in women 
1SD WHR =6.0% in men, =6.4% in women 
1SD WHtR=5.1% in men, =5.5% in women 
1SD body fat %=5.6 % in men, =6.9 % in women 
Adjustment include age, height, education, smoking, occupation, physical activity, airflow 
obstruction self-reported asthma and wheezing as appropriate. 
*: further adjusted for BMI  
＃: further adjusted for WC 
†: n=6397, missing values were excluded here only. 
 
